_:n920b5f266d8240fa80d0b807f4b3790axb0
<http://schema.org/overdosage>
"No specific information is available on the treatment of overdose with irbesartan/HCT. The patient should be closely monitored, and the treatment should be symptomatic and supportive. Management depends on the time since ingestion and the severity of the symptoms. Suggested measures include induction of emesis and/or gastric lavage. Activated charcoal may be useful in the treatment of overdose. Serum electrolytes and creatinine should be monitored frequently. If hypotension occurs, the patient should be placed in a supine position, with salt and volume replacements given quickly.\r\nThe most likely manifestations of irbesartan overdose are expected to be hypotension and tachycardia; bradycardia might also occur.\r\nOverdose with hydrochlorothiazide is associated with electrolyte depletion (hypokalaemia, hypochloremia, hyponatraemia) and dehydration resulting from excessive diuresis. The most common signs and symptoms of overdose are nausea and somnolence. Hypokalaemia may result in muscle spasms and/or accentuate cardiac arrhythmias associated with the concomitant use of digitalis glycosides or certain anti-arrhythmic medicinal products.\r\nIrbesartan is not removed by haemodialysis. The degree to which hydrochlorothiazide is removed by haemodialysis has not been established."
<https://www.medthority.com/drugs/c-cardiovascular-system/c09/c09d/c09da/c09da04/irbesartan-hydrochlorothiazide-actavis-300mg25mg-film-coated-tablets/>